 |
 |
|
|
RESÚMENES OCTUBRE 2007 |
Mood - Anxiety
Disorders & Antidepressants – Mood Stabilizers
(Haga un click en la información del journal para acceder al resúmen)
5 –
doble-ciego o metanálisis; 4 – subanálisis
o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión
5 - Functional Neuroimaging of Anxiety: A Meta-Analysis of Emotional
Processing in PTSD, Social Anxiety Disorder, and Specific Phobia
Amit Etkin
and Tor D. Wager
Am J Psychiatry 2007
164: 1476-1488
3! - Clinically Identified
Maternal Depression Before, During, and After Pregnancies Ending in Live Births
Patricia M. Dietz, Selvi B. Williams, William M. Callaghan, Donald J. Bachman,
Evelyn P. Whitlock, and Mark C. Hornbrook
Am J Psychiatry 2007
164: 1515-1520
3 - Association of Different
Adverse Life Events With Distinct Patterns of
Depressive Symptoms
Matthew C. Keller, Michael C. Neale, and Kenneth S. Kendler
Am J Psychiatry 2007
164: 1521-1529
3! - Effect of Age at Onset on the
Course of Major Depressive Disorder
Sidney Zisook,
Ira Lesser, Jonathan W. Stewart, Stephen R. Wisniewski, G.K. Balasubramani, Maurizio Fava,
William S. Gilmer, Timothy R. Dresselhaus, Michael E.
Thase, Andrew A. Nierenberg, Madhukar
H. Trivedi, and A. John Rush
Am J Psychiatry 2007
164: 1539-1546
3! - Genetic Markers of Suicidal
Ideation Emerging During Citalopram Treatment of
Major Depression
Gonzalo Laje,
Silvia Paddock, Husseini Manji,
A. John Rush, Alexander F. Wilson, Dennis Charney,
and Francis J. McMahon
Am J Psychiatry 2007
164: 1530-1538
3 -
Pharmacokinetics and Absolute Bioavailability of Selegiline
Following Treatment of Healthy Subjects With the Selegiline Transdermal System (6
mg/24 h): A Comparison With Oral Selegiline Capsules
Albert J. Azzaro, John Ziemniak,
Eva Kemper, Bryan J. Campbell, and
J Clin Pharmacol
2007 47: 1256
3 -
Chocolate craving when depressed: a personality marker
GORDON PARKER, and JOANNA CRAWFORD
The British Journal of Psychiatry (2007) 191:
351-352
3 -
Behavioral effects of the β3 adrenoceptor
agonist SR58611A: Is it the putative prototype of a new class of
antidepressant/anxiolytic drugs?
Daniele Consoli, Gian Marco Leggio, Carmen Mazzola, Vincenzo Micale and
Filippo Drago
European
Journal of Pharmacology. Volume 573, Issues 1-3, 14 November 2007, Pages 139-147
3! - Getting Better, Getting Well: Understanding and
Managing Partial and Non-Response to Pharmacological Treatment of Non-Psychotic
Major Depression in Old Age. Therapy In Practice
Driscoll, Henry C;
Drugs & Aging. 24(10):801-814, 2007
5 - Quetiapine
adjunct to selective serotonin reuptake inhibitors or venlafaxine
in patients with major depression, comorbid anxiety,
and residual depressive symptoms: a randomized, placebo-controlled pilot study
Alexander McIntyre, Alain Gendron, Amanda McIntyre
Depression and Anxiety. Volume 24, Issue 7, Pages 487 - 494
3 - Aripiprazole
augmentation for treatment of patients with inadequate antidepressants response
Chi-Un Pae, Ashwin A. Patkar, Tae-Youn Jun, Chul Lee, Prakash
Depression and Anxiety. Volume 24, Issue 7, Pages 522 - 526
3< -
The Relationship Between Cerebrospinal Fluid
Biomarkers and Depression in Elderly Women
Pia Gudmundsson, Ingmar Skoog, Margda Waern, Kaj
Blennow, Sigurdur Pálsson, Lars Rosengren, and
Deborah Gustafson
Am J Geriatr Psychiatry
15:832-838, October 2007
4 - Evidence for the efficacy of duloxetine in treating mild, moderate, and severe
depression
Shelton, Richard C; Andorn,
Anne C; Mallinckrodt, Craig H; Wohlreich, Madelaine M; Raskin, Joel; Watkin, John G; Detke, Michael J
International Clinical
Psychopharmacology. 22(6):348-355,
November 2007
3 - Which antidepressants have demonstrated
superior efficacy? A review of the evidence
Montgomery, Stuart A; Baldwin, David S; Blier, Pierre; Fineberg, Naomi A;
Kasper, Siegfried; Lader, Malcolm; Lam, Raymond W; Lepine, Jean-Pierre; Moller,
Hans-Jurgen; Nutt, David J; Rouillon,
Frederic; Schatzberg, Alan F. l; Thase,
Michael E
International Clinical
Psychopharmacology. 22(6):323-329,
November 2007
4< - A randomized, single-blind, comparison of venlafaxine with paroxetine in
elderly patients suffering from resistant depression
Mazeh, Doron; Shahal, Baruch; Aviv, Alex; Zemishlani,
Hanna; Barak, Yoram
International Clinical
Psychopharmacology. 22(6):371-375,
November 2007
5 - Sustained response versus relapse: the pharmacotherapeutic goal for obsessive-compulsive disorder
Fineberg, Naomi A; Pampaloni, Ilenia; Pallanti, Stefano; Ipser, Jonathan; Stein, Dan J
International Clinical
Psychopharmacology. 22(6):313-322,
November 2007
2! - Valproate-induced
hyperammonaemic encephalopathy: review of 14 cases in
the psychiatric setting
Dealberto, Marie-Jose C.C
International Clinical
Psychopharmacology. 22(6):330-337,
November 2007
3< - Quetiapine
for the continuation treatment of bipolar depression: naturalistic prospective
case series from the
Suppes, Trisha; Kelly, Dorothy I; Keck, Paul E. Jr; McElroy, Susan L; Altshuler,
Lori L; Mintz, Jim; Frye, Mark A; Nolen, Willem A; Luckenbaugh, David A; Post, Robert M; Leverich,
Gabriele S; Kupka, Ralph W; Grunze,
Heinz
International Clinical
Psychopharmacology. 22(6):376-381,
November 2007
3 -
Treatment of bipolar disorder: a complex treatment for a multi-facet disorder
Konstantinos N Fountoulakis, Eduard Vieta, Melina
Siamouli, Marc Valenti, Stamatia Magiria, Timucin Oral, David Fresno,
Panteleimon Giannakopoulos and George S Kaprinis
Annals
of General Psychiatry 2007, 6:27
TEXTO GRATUITO
3! - Evidence for Two Types of Bipolar
Depression Using a Dimensional Approach
Chantal Henry, Katia M'Baïlara, Rollon Poinsot, Anne-Aurelie Casteret, Frédéric Sorbara, Marion Leboyer, Eduard Vieta
Psychotherapy
and Psychosomatics 2007;76:325-331
3 -
Recurrences of bipolar disorders – Comparative study of bipolar disorders,
recurring depressions and single depressions in a cohort of patients aged over
65 years
F. Galland,
E. Vaille-Perret, L. Gerbaud, I. Jalenques
L’Encephale. Vol 33 - N° 4-C1 - Septembre 2007 :
544 - 549
3 - The interaction between the
internal clock and antidepressant efficacy
Racagni,
Giorgio; Riva, Marco A.; Popoli, Maurizio
International Clinical Psychopharmacology.
22 Supplement 2:S9-S14, October 2007
3! - No increased incidence of diabetes in
antidepressant users
Knol, Mirjam J; Geerlings, Mirjam I; Egberts, Antoine C.G; Gorter, Kees J; Grobbee, Diederick E; Heerdink, Eibert R
International
Clinical Psychopharmacology. 22(6):382-386, November 2007
3! - Evaluating suicide-related adverse
events in clinical trials of fluoxetine treatment in
adults for indications other than major depressive disorder
SITRA TAUSCHER-WISNIEWSKI, DAMON
DISCH, JOHN PLEWES, SUSAN BALL and CHARLES M. BEASLEY Jr
Psychological
Medicine (2007), 37: 1585-1593
3 - Clinical and prognostic
implications of seasonal pattern in bipolar disorder: a 10-year follow-up of
302 patients
J. M. GOIKOLEA, F. COLOM,
A. MARTÍNEZ-ARÁN, J. SÁNCHEZ-MORENO, A. GIORDANO, A. BULBENA and E. VIETA
Psychological
Medicine (2007), 37: 1595-1599
5< - Repetitive transcranial magnetic stimulation for the treatment of
obsessive compulsive disorder: a double-blind controlled investigation
PERMINDER S. SACHDEV, COLLEEN
K. LOO, PHILIP B. MITCHELL, TARA F. McFARQUHAR and
GIN S. MALHI
Psychological
Medicine (2007), 37: 1645-1649
3 -
Suicidal ideation in pregnancy: assessment and clinical implications
D.
J. Newport, L. C. Levey, P.
B. Pennell, K. Ragan and Z. N. Stowe
Archives of Women's Mental Health. Volume 10, Number 5 / october 2007: 181-187
3 - Do
oral contraceptives act as mood stabilizers? Evidence of positive affect
stabilization
J. A. Jarva and K. A. Oinonen
Archives of Women's Mental Health. Volume 10, Number 5 / october 2007: 225-234
3 -
Long-term and preventative treatment for seasonal affective disorder
Westrin A, Lam RW
3 -
Major depression in temporal lobe epilepsy with hippocampal
sclerosis: clinical and imaging correlates
Regula S Briellmann, Malcolm J Hopwood,
Graeme D Jackson
Journal
of Neurology, Neurosurgery, and Psychiatry 2007;78:1226-1230
5 -
Aripiprazole Monotherapy
for Maintenance Therapy in Bipolar I Disorder: A 100-Week, Double-Blind Study
Versus Placebo
Paul E. Keck, Jr., Joseph R. Calabrese,
Roger S. McIntyre, Robert D. McQuade, William H.
Carson, James M. Eudicone, Berit
X. Carlson, Ronald N. Marcus, and Raymond Sanchez, for the Aripiprazole
Study Group
J Clin Psychiatry 2007;68:1480-1491
3 -
A Pharmacokinetic and Clinical Evaluation of Switching Patients With Bipolar I Disorder From Delayed-Release to
Extended-Release Divalproex
Lori L. Davis, Xiaohua
Li, Al A. Bartolucci, Raela
B. Williford, and Joette S.
Lowe
J Clin Psychiatry 2007;68:1546-1551
3! -
Self-Reported History of Manic/Hypomanic Switch
Associated With Antidepressant Use: Data From the
Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
Christine J. Truman, Joseph F. Goldberg, S.
Nassir Ghaemi, Claudia F. Baldassano,
Stephen R. Wisniewski, Ellen B. Dennehy, Michael E. Thase, and Gary S. Sachs
J Clin Psychiatry 2007;68:1472-1479
3 - Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive
disorder
Ramin Saghafi,
Charlotte Brown, Meryl A. Butters, Jill Cyranowski,
Mary Amanda Dew, Ellen Frank, Ariel Gildengers,
Jordan F. Karp, Eric J. Lenze, Francis Lotrich, Lynn Martire, Sati Mazumdar, Mark D. Miller, Benoit H. Mulsant,
Elizabeth Weber, Ellen Whyte, Jennifer Morse,
Jacqueline Stack, Patricia R. Houck, Salem Bensasi,
Charles F. Reynolds III
International Journal of Geriatric Psychiatry. Volume 22, Issue 11, Pages 1141 - 1146
3 -
Treatment of Depression During Pregnancy
Cynthia Feucht
TEXTO GRATUITO
3! - Chronic Duloxetine Treatment Induces Specific Changes in the
Expression of BDNF Transcripts and in the Subcellular
Localization of the Neurotrophin Protein
Francesca Calabrese,
Raffaella Molteni, Paola F Maj, Annamaria Cattaneo,
Massimo Gennarelli, Giorgio Racagni and Marco A Riva
Neuropsychopharmacology (2007) 32, 2351–2359
3 - Antiplatelet Properties of Escitalopram
in Patients with the Metabolic Syndrome: A Dose-Ranging In Vitro Study
Dan Atar, Alex Malinin,
Alex Pokov, Louis van Zyl,
Nancy Frasure-Smith, Francois Lesperance and Victor L Serebruany
Neuropsychopharmacology (2007) 32, 2369–2374
5 -
A randomized, double-blind comparison of duloxetine
and venlafaxine in the treatment of patients with
major depressive disorder
David G.S. Perahia, Yili Lu Pritchett,
Daniel K. Kajdasz, Michael Bauer, Rakesh
Jain, James M. Russell, Daniel J. Walker, Kimberly A. Spencer, Debbie M. Froud, Joel Raskin and Michael E.
Thase
Journal
of Psychiatric Research. Volume 42, Issue 1, January 2008, Pages 22-34
3! -
Lifetime Major Depression is Associated With
Coronary Heart Disease in Older Adults: Results From the National Epidemiologic
Survey on Alcohol and Related Conditions
Sarah Herbst, Robert H. Pietrzak,
Julie Wagner, William B. White, and Nancy M. Petry
Psychosomatic Medicine 69:729-734 (2007)
3! - A
Longitudinal Typology of Symptoms of Depression and Anxiety Over
the Life Course
Ian Colman, George B. Ploubidis, Michael E.J. Wadsworth, Peter B. Jones, Tim J. Croudace
3 -
Desvenlafaxine Succinate
Identifies Novel Antagonist Binding Determinants in the Human Norepinephrine Transporter
John N. Mason, Darlene C. Deecher, Rhonda L.
Richmond, Gary Stack, Paige E. Mahaney, Eugene Trybulski, Richard C. Winneker,
and Randy D. Blakely
3 - Increase in use of selective serotonin reuptake
inhibitors in pregnancy during the last decade, a population-based cohort study
from the Netherlands
Marian K. Bakker, Pieternel
Kölling, Paul B. van den Berg, Hermien
E. K. de Walle, Lolkje T.
W. de Jong van den Berg
British Journal of Clinical Pharmacology (OnlineEarly Articles) November 2007
3 - D-Cycloserine Augmented Exposure Therapy for
Obsessive-Compulsive Disorder
Matt G. Kushner, Suck
Won Kim, Christopher Donahue, Paul Thuras, David Adson, Michael Kotlyar, James
McCabe, Jillian Peterson and Edna B. Foa
Biological
Psychiatry. Volume 62, Issue 8, 15 October 2007, Pages 835-838
3 - High Occupancy of Sigma-1 Receptors in the Human Brain after Single Oral Administration of Fluvoxamine: A Positron Emission Tomography Study Using [11C]SA4503